Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Ironwood Pharmaceuticals stock

Learn how to easily invest in Ironwood Pharmaceuticals stock.

Ironwood Pharmaceuticals is a drug manufacturers-specialty & generic business based in the US. Ironwood Pharmaceuticals shares (IRWD) are listed on the NASDAQ and all prices are listed in US Dollars. Ironwood Pharmaceuticals employs 219 staff and has a trailing 12-month revenue of around $420.5 million.

How to buy Ironwood Pharmaceuticals stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – IRWD. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience

Robinhood


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance

Promoted

tastyworks


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Ironwood Pharmaceuticals stock price (NASDAQ: IRWD)

Use our graph to track the performance of IRWD stocks over time.

Ironwood Pharmaceuticals shares at a glance

Information last updated 2023-01-25.
Latest market close$11.31
52-week range$9.73 - $12.95
50-day moving average $11.84
200-day moving average $11.48
Wall St. target price$13.00
PE ratio 12.3226
Dividend yield $0 (0%)
Earnings per share (TTM) $0.93

Buy Ironwood Pharmaceuticals stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Ironwood Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Ironwood Pharmaceuticals price performance over time

Historical closes compared with the close of $11.31 from 2023-01-26

1 week (2023-01-20) -0.88%
1 month (2022-12-27) -7.30%
3 months (2022-10-27) 3.67%
6 months (2022-07-27) -8.50%
1 year (2022-01-26) 4.24%
2 years (2021-01-27) 8.85%
3 years (2020-01-27) 12.18
5 years (2018-01-26) 16.2702

Is Ironwood Pharmaceuticals stock undervalued or overvalued?

Valuing Ironwood Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ironwood Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Ironwood Pharmaceuticals's P/E ratio

Ironwood Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 12x. In other words, Ironwood Pharmaceuticals shares trade at around 12x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Ironwood Pharmaceuticals's EBITDA

Ironwood Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $240.3 million.

The EBITDA is a measure of a Ironwood Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.

Ironwood Pharmaceuticals financials

Revenue TTM $420.5 million
Operating margin TTM 56.8%
Gross profit TTM $343.3 million
Return on assets TTM 14.09%
Return on equity TTM 28.62%
Profit margin 39.85%
Book value $3.86
Market capitalisation $1.8 billion

TTM: trailing 12 months

Ironwood Pharmaceuticals share dividends

We're not expecting Ironwood Pharmaceuticals to pay a dividend over the next 12 months.

Have Ironwood Pharmaceuticals's shares ever split?

Ironwood Pharmaceuticals's shares were split on a 1194:1000 basis on 1 April 2019. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1194 shares. This wouldn't directly have changed the overall worth of your Ironwood Pharmaceuticals shares – just the quantity. However, indirectly, the new 16.2% lower share price could have impacted the market appetite for Ironwood Pharmaceuticals shares which in turn could have impacted Ironwood Pharmaceuticals's share price.

Ironwood Pharmaceuticals share price volatility

Over the last 12 months, Ironwood Pharmaceuticals's shares have ranged in value from as little as $9.73 up to $12.95. A popular way to gauge a stock's volatility is its "beta".

IRWD.US volatility(beta: 0.95)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ironwood Pharmaceuticals's is 0.9487. This would suggest that Ironwood Pharmaceuticals's shares are less volatile than average (for this exchange).

Ironwood Pharmaceuticals overview

Ironwood Pharmaceuticals, Inc. , a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104, an immune nanoparticle for the treatment of biliary cholangitis. The company has strategic partnerships with AbbVie Inc. , AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide.

Frequently asked questions

What percentage of Ironwood Pharmaceuticals is owned by insiders or institutions?
Currently 1.54% of Ironwood Pharmaceuticals shares are held by insiders and 115.657% by institutions.
How many people work for Ironwood Pharmaceuticals?
Latest data suggests 219 work at Ironwood Pharmaceuticals.
When does the fiscal year end for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals's fiscal year ends in December.
Where is Ironwood Pharmaceuticals based?
Ironwood Pharmaceuticals's address is: 100 Summer Street, Boston, MA, United States, 02110
What is Ironwood Pharmaceuticals's ISIN number?
Ironwood Pharmaceuticals's international securities identification number is: US46333X1081
What is Ironwood Pharmaceuticals's CUSIP number?
Ironwood Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 46333X108

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site